|
NEK1 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.62447832963153E-12 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
<1E-12 |
| Normal-vs-Stage2 |
7.47957251689968E-13 |
| Normal-vs-Stage3 |
<1E-12 |
| Normal-vs-Stage4 |
1.62436730732907E-12 |
| Stage1-vs-Stage2 |
7.409600E-01 |
| Stage1-vs-Stage3 |
2.673800E-01 |
| Stage1-vs-Stage4 |
3.738100E-03 |
| Stage2-vs-Stage3 |
3.172400E-01 |
| Stage2-vs-Stage4 |
1.637900E-02 |
| Stage3-vs-Stage4 |
1.125250E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
<1E-12 |
| Normal-vs-AfricanAmerican |
6.91339985259276E-10 |
| Normal-vs-Asian |
1.65822910958013E-12 |
| Caucasian-vs-AfricanAmerican |
8.636200E-01 |
| Caucasian-vs-Asian |
7.904400E-01 |
| AfricanAmerican-vs-Asian |
9.806200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
<1E-12 |
| Normal-vs-Female |
1.62436730732907E-12 |
| Male-vs-Female |
1.752150E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.62436730732907E-12 |
| Normal-vs-Age(41-60Yrs) |
<1E-12 |
| Normal-vs-Age(61-80Yrs) |
1.62447832963153E-12 |
| Normal-vs-Age(81-100Yrs) |
2.198700E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.473000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.884000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.625400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.178400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.768600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.938200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
2.610500E-02 |
| Classical-VS-Follicular |
6.891000E-01 |
| Classical-VS-Other |
1.486380E-01 |
| Classical-VS-Normal |
3.66373598126302E-15 |
| Tall-VS-Follicular |
1.541550E-02 |
| Tall-VS-Other |
7.272600E-01 |
| Tall-VS-Normal |
<1E-12 |
| Follicular-VS-Other |
2.005000E-01 |
| Follicular-VS-Normal |
1.68420832835636E-12 |
| Other-VS-Normal |
2.28440000005214E-06 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
<1E-12 |
| Normal-vs-N1 |
<1E-12 |
| N0-vs-N1 |
1.176460E-02 |
|
|
